Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Early tumorigenesis is associated with the engagement of the DNA-damage checkpoint response (DDR). Cell proliferation and transformation induced by oncogene activation are restrained by cellular senescence. It is unclear whether DDR activation and oncogene-induced senescence (OIS) are causally linked. Here we show that senescence, triggered by the expression of an activated oncogene (H-RasV12) in normal human cells, is a consequence of the activation of a robust DDR. Experimental inactivation of DDR abrogates OIS and promotes cell transformation. DDR and OIS are established after a hyper-replicative phase occurring immediately after oncogene expression. Senescent cells arrest with partly replicated DNA and with DNA replication origins having fired multiple times. In vivo DNA labelling and molecular DNA combing reveal that oncogene activation leads to augmented numbers of active replicons and to alterations in DNA replication fork progression. We also show that oncogene expression does not trigger a DDR in the absence of DNA replication. Last, we show that oncogene activation is associated with DDR activation in a mouse model in vivo. We propose that OIS results from the enforcement of a DDR triggered by oncogene-induced DNA hyper-replication.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Inhibition of DDR signalling kinases (ATM, ATR, CHK1 and CHK2) allows senescent cells to re-enter the cell cycle7,24,25”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [7]
In the citing paper
“Oncogene activation is a powerful inducer of cellular senescence. Oncogene expression triggers an initial hyperproliferative phase that is intrinsically associated with altered DNA replication, which eventually engages DDR pathways and causes senescence7,8,39”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [7]
In the citing paper
“In normal cells, however, oncogenic RAS causes genotoxic stress and senescence [ 57 , 58 ], inducing a SASP and thereby conferring complex cell-nonautonomous oncogenic activities.”
From Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor (2008) · cites this paper as [57]
In the citing paper
“Indeed, most oncogenes that have been studied in the literature cause replication stress by increasing origin firing and triggering DNA damage [12, 29]”
From The Spi1/PU.1 transcription factor accelerates replication fork progression by increasing PP1 phosphatase in leukemia (2017) · cites this paper as [12]
In the citing paper
“It has been shown that one mechanism for the link between the initial mitotic reaction and senescence induction is the S-phase-associated DDR: The oncogenic stress drives increased DNA replication origins, leading to accumulation of incomplete replication intermediates, resulting in DNA damage and activation of the DDR kinases (ATM, ATR, CHK2, and CHK1) (Bartkova et al. 2006; Di Micco et al. 2006;”
From Cellular senescence and its effector programs (2014) · cites this paper as Di Micco et al. 2006
14 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
1 retracted
Oncogenic activity of Cdc6 through repression of the INK4/ARF locus
Gonzalez, S., Klatt, P., Delgado, S., Conde, E., Lopez-Rios, F., Sanchez-Cespedes, M., Mendez, J., Antequera, F., & Serrano, M. (2006) · Nature · doi:10.1038/nature04585 · Cited by 186
RetractedA biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
A DNA damage checkpoint response in telomere-initiated senescence
Fagagna, F. D. D., Reaper, P. M., Clay-Farrace, L., Fiegler, H., Carr, P., von Zglinicki, T., Saretzki, G., Carter, N. P., & Jackson, S. P. (2003) · Nature · doi:10.1038/nature02118 · Cited by 2,917
Cell-cycle checkpoints and cancer
Kastan, M. B., & Bartek, J. (2004) · Nature · doi:10.1038/nature03097 · Cited by 2,836
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
Bartkova, J., Hořejší, Z., Koed, K., Krämer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland, J. M., Lukas, C., et al. (2005) · Nature · doi:10.1038/nature03482 · Cited by 2,688
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278
BRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions
Gorgoulis, V. G., Vassiliou, L.-V. F., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., DiTullio, R. A., Kastrinakis, N. G., Levy, B., et al. (2005) · Nature · doi:10.1038/nature03485 · Cited by 2,009
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
Chen, Z., Trotman, L. C., Shaffer, D., Lin, H.-K., Dotan, Z. A., Niki, M., Koutcher, J. A., Scher, H. I., Ludwig, T., Gerald, W., et al. (2005) · Nature · doi:10.1038/nature03918 · Cited by 1,993
Cited by
Items 301–400 of 1,011
Gonzalez-Meljem, J. M., Haston, S., Carreno, G., Apps, J. R., Pozzi, S., Stache, C., Kaushal, G., Virasami, A., Panousopoulos, L., Mousavy-Gharavy, S. N., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01992-5 · Cited by 130
“Prominent or persistent SASP activation has been shown to: (1) disrupt cell–cell adhesion and induce epithelial-tomesenchymal transition and invasiveness14, 15; (2) cause local inflammation12, 16; (3) modify tissue architecture17, 18; (4) facilitate development of hepatic cancer after carcinogen exposure19, 20; (5) st…”
BackgroundAlternative Cyclin D1 Splice Forms Differentially Regulate the DNA Damage Response
Li, Z., Jiao, X., Wang, C., Shirley, L. A., Elsaleh, H., Dahl, O., Wang, M., Soutoglou, E., Knudsen, E. S., & Pestell, R. G. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0312 · Cited by 124
Splicing-Factor Oncoprotein SRSF1 Stabilizes p53 via RPL5 and Induces Cellular Senescence
Fregoso, O. I., Das, S., Akerman, M., & Krainer, A. R. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.02.001 · Cited by 130
“…by SRSF1 overexpression in normal cells is distinct from the classical Rasinduced senescence (Serrano et al., 1997), which is primarily a DNA-damage response induced by hyperproliferation, and is dependent on p16 activation (Bartkova et al., 2006; Chicas et al., 2010; Di Micco et al., 2006).”
BackgroundVougas, K. N., Sakellaropoulos, T., Kotsinas, A., Foukas, G.-R. P., Ntargaras, A., Koinis, F., Polyzos, A., Myrianthopoulos, V., Zhou, H., Narang, S., et al. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.107395 · Cited by 138
Mechanisms and significance of therapy-induced and spontaneous senescence of cancer cells
Mikuła-Pietrasik, J., Niklas, A., Uruski, P., Tykarski, A., & Książek, K. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03261-8 · Cited by 119
“Significantly, the induction of senescence related to the inhibition of PTEN does not involve initial hyperproliferation and DNA damage response, which may be more profitable from the perspective of therapeutic application compared with OIS, in which both these reactions are present [171].”
BackgroundJia, L., Soengas, M. S., & Sun, Y. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4671 · Cited by 131
Cytokine expression and signaling in drug-induced cellular senescence
Novakova, Z., Hubackova, S., Kosar, M., Janderova-Rossmeislova, L., Dobrovolna, J., Vasicova, P., Vancurova, M., Horejsi, Z., Hozak, P., Bartek, J., et al. (2010) · Oncogene · doi:10.1038/onc.2009.318 · Cited by 127
“…senescence in vitro were also found in preinvasive lesions of multiple types of human tumors (Michaloglou et al., 2005; Bartkova et al., 2006; Di Micco et al., 2006; Collado et al., 2007; Acosta et al., 2008; Kuilman et al., 2008), supporting a view that cellular senescence acts as a…”
BackgroundInfluentialCommon Chemical Inductors of Replication Stress: Focus on Cell‐Based Studies
Vesela, E., Chroma, K., Turi, Z., & Mistrik, M. (2017) · Biomolecules · doi:10.3390/biom7010019 · Cited by 115
“Moreover, a causative role of CFS’s in cancer development has been suggested [191].”
BackgroundInfluentialThe DNA Damage Response in Neurons: Die by Apoptosis or Survive in a Senescence-Like State?
Fielder, E., von Zglinicki, T., & Jurk, D. (2017) · Journal of Alzheimer's Disease · doi:10.3233/jad-161221 · Cited by 126
Extracellular Vesicles as New Players in Cellular Senescence
Urbanelli, L., Buratta, S., Sagini, K., Tancini, B., & Emiliani, C. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17091408 · Cited by 122
“How can oncogenic signals, which are implicated in the development of a pathology characterized by deregulated proliferation, actually induce senescence, whose main feature is proliferation arrest? Paradoxically, oncogene activation induces senescence at least in part by inducing DNA damage, leading to the persistent…”
BackgroundThe DNA Damage Signaling Pathway Connects Oncogenic Stress to Cellular Senescence
Mallette, F. A., & Ferbeyre, G. (2007) · Cell Cycle · doi:10.4161/cc.6.15.4516 · Cited by 125
Hein, J., Boichuk, S., Wu, J., Cheng, Y., Freire, R., Jat, P., Roberts, T. M., & Gjoerup, O. V. (2008) · Journal of Virology · doi:10.1128/jvi.01515-08 · Cited by 137
“Recent reports have demonstrated that both replicative and oncogene-induced senescences reflect an underlying persistent activation of DDRs that are likely triggered by aberrant cellular DNA replication (4, 17, 21).”
BackgroundMallette, F. A., & Richard, S. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.09.033 · Cited by 120
“This DNA damage response triggered by the PIK-related kinase ATM is required to activate p53 during OIS (Bartkova et al., 2006; Di Micco et al., 2006; Mallette et al., 2007).”
BackgroundRasmussen, R. D., Gajjar, M. K., Tučková, L., Jensen, K. E., Maya‐Mendoza, A., Holst, C. B., Møllgaard, K., Rasmussen, J. S., Brennum, J., Bartek, J. J., et al. (2016) · Nature Communications · doi:10.1038/ncomms13398 · Cited by 135
“DDR activation is thought to reflect DNA RS (refs 12,13,27,28) and, consistently, BRCA1 knockdown in GBM cells led to the activation of ATM/Chk2-Chk1/RPA signalling (Fig.”
The role of Stat5 transcription factors as tumor suppressors or oncogenes
Ferbeyre, G., & Moriggl, R. (2010) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2010.10.004 · Cited by 143
Regulation of cellular senescence via the FOXO 4‐p53 axis
Bourgeois, B., & Madl, T. (2018) · FEBS Letters · doi:10.1002/1873-3468.13057 · Cited by 119
Cellular senescence and cardiovascular diseases: moving to the “heart” of the problem
Evangelou, K., Vasileiou, P. V. S., Papaspyropoulos, A., Hazapis, O. G., Petty, R., Demaria, M., & Gorgoulis, V. G. (2022) · Physiological Reviews · doi:10.1152/physrev.00007.2022 · Cited by 136
Loss of Rb proteins causes genomic instability in the absence of mitogenic signaling
van Harn, T., Foijer, F., van Vugt, M., Banerjee, R., Yang, F., Oostra, A., Joenje, H., & te Riele, H. (2010) · Genes & Development · doi:10.1101/gad.580710 · Cited by 124
“Interestingly, a DDR has been observed previously upon activation of various oncogenes, and has been as- cribed to stalling and collapse of replication forks (Bartkova et al. 2006; Di Micco et al. 2006; Halazonetis et al. 2008).”
BackgroundAttenuation of TORC1 signaling delays replicative and oncogenic RAS-induced senescence
Kolesnichenko, M., Hong, L., Liao, R., Vogt, P. K., & Sun, P. (2012) · Cell Cycle · doi:10.4161/cc.20683 · Cited by 123
“Overexpression of oncogenic RAS also leads to activation of the DNA damage response.(13,14) Unlike RAS-induced senescence, replicative senescence develops slowly and occurs after approximately 50 cell divisions ex vivo in human cells.”
BackgroundLeung, J. W.-C., Ghosal, G., Wang, W., Shen, X., Wang, J., Li, L., & Chen, J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.411603 · Cited by 117
“Impaired replication fork progression and increased replication-dependent DNA damage were found in early stages of tumor development (35, 36).”
The Paradoxical Role of Cellular Senescence in Cancer
Yang, J., Liu, M., Hong, D., Zeng, M., & Zhang, X. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.722205 · Cited by 114
Cellular senescence: Neither irreversible nor reversible
Reimann, M., Lee, S., & Schmitt, C. A. (2024) · The Journal of Experimental Medicine · doi:10.1084/jem.20232136 · Cited by 136
Bermejo, R., Capra, T., González‐Huici, V., Fachinetti, D., Cocito, A., Natoli, G., Katou, Y., Mori, H., Kurokawa, K., Shirahige, K., et al. (2009) · Cell · doi:10.1016/j.cell.2009.06.022 · Cited by 122
A “Twist box” Code of p53 Inactivation: Twist box:p53 Interaction Promotes p53 Degradation
Piccinin, S., Tonin, E., Sessa, S., Demontis, S., Rossi, S., Pecciarini, L., Zanatta, L., Pivetta, F., Grizzo, A., Sonego, M., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.08.003 · Cited by 130
“…expressing MDM2, dnp53, shp53, or Twist were subcutaneously injected into each flank of six-week-old athymic nude mice (Hsd:Athymic nude-nu, Harlan) as previously described (Di Micco et al., 2006; Seger et al., 2002) For pRetroSuper-shLuc and pRetroSuper-shTwist HT-1080, 1 3 106 cells were used.”
BackgroundMethodSelf-citationSchlitter, A. M., Segler, A., Steiger, K., Michalski, C. W., Jäger, C., Konukiewitz, B., Pfarr, N., Endris, V., Bettstetter, M., Kong, B., et al. (2017) · Scientific Reports · doi:10.1038/srep41064 · Cited by 112
Oncogenic miR-181a/b affect the DNA damage response in aggressive breast cancer
Bisso, A., Faleschini, M., Zampa, F., Capaci, V., Santa, J. D., Santarpia, L., Piazza, S., Cappelletti, V., Daidone, M. G., Agami, R., et al. (2013) · Cell Cycle · doi:10.4161/cc.24757 · Cited by 131
Skin-Aging Pigmentation: Who Is the Real Enemy?
Kim, J. C., Park, T. J., & Kang, H. Y. (2022) · Cells · doi:10.3390/cells11162541 · Cited by 135
The STAT3-IGFBP5 axis is critical for IL-6/gp130-induced premature senescence in human fibroblasts
Kojima, H., Kunimoto, H., Inoue, T., & Nakajima, K. (2012) · Cell Cycle · doi:10.4161/cc.11.4.19172 · Cited by 114
“ROS generation and the subsequent DDR have recently been reported to be involved in p53-dependent premature cellular senescence.(10,33) To test whether ROS are generated in IL-6/sIL-6R-induced premature senescence, we stained TIG3 cells with H 2 DCFDA, a compound that fluoresces in the presence of high ROS levels.”
MethodStressing the cell cycle in senescence and aging
Chandler, H., & Peters, G. (2013) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2013.07.005 · Cited by 119
Cell Cycle–Targeted Cancer Therapies
Sherr, C. J., & Bártek, J. (2016) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-040716-075628 · Cited by 130
“…for abnormalities in the DDR machinery in nascent tumor cells is replication stress (RS), which is driven by the activation of oncogenes or the loss of certain tumor suppressors (Bartkova et al. 2005, Di Micco et al. 2006, Gorgoulis et al. 2005, Halazonetis et al. 2008, Hills & Diffley 2014).”
BackgroundNayak, S. U., Calvo, J. A., Cong, K., Peng, M., Berthiaume, E. A., Jackson, J., Zaino, A. M., Vindigni, A., Hadden, M. K., & Cantor, S. B. (2020) · Science Advances · doi:10.1126/sciadv.aaz7808 · Cited by 120
Role of cellular senescence in inflammation and regeneration
Saito, Y., Yamamoto, S., & Chikenji, T. (2024) · Inflammation and Regeneration · doi:10.1186/s41232-024-00342-5 · Cited by 140
Cellular senescence: hot or what?
Evan, G. I., & di Fagagna, F. D. (2009) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.11.009 · Cited by 151
Mechanisms to control rereplication and implications for cancer
Hook, S. S., Lin, J. J., & Dutta, A. (2007) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2007.10.007 · Cited by 138
Wu, Z., Qu, J., & Liu, G.-H. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-024-00775-3 · Cited by 118
“For example, oncogene activation can induce extensive replication fork stalling, thereby inducing a robust DDR, which in turn results in growth arrest and senescence in normal human fibroblasts, without involving telomere attrition 117–119 .”
Prieur, A., Besnard, E., Babled, A., & Lemaitre, J.-M. (2011) · Nature Communications · doi:10.1038/ncomms1473 · Cited by 117
Bártková, J., Hořejší, Z., Sehested, M., Nesland, J. M., Meyts, E. R., Skakkebæk, N. E., Stucki, M., Jackson, S. P., Lukáš, J., & Bártek, J. (2007) · Oncogene · doi:10.1038/sj.onc.1210553 · Cited by 128
“…create an environment in which inactivating mutations within the DDR network are selected for in lesions that eventually overcome the DDR-induced cell death or senescence pathways and progress towards malignancy (Bartkova et al., 2005b, 2006; Gorgoulis et al., 2005; Di Micco et al., 2006).”
BackgroundMaehara, K., Takahashi, K., & Saitoh, S. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01318-09 · Cited by 104
“To test whether DDR plays a crucial role in p53 activation in senescencelike cells depleted of CENP-A, we examined the presence of DNA damage foci by immunofluorescence assay using antibody against phosphorylated histone H2A.”
BackgroundInfluentialOncogene-induced senescence: From biology to therapy
Zhu, H., Blake, S., Kusuma, F. K., Pearson, R. B., Kang, J., & Chan, K. T. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111229 · Cited by 116
Schmitt, E., Paquet, C., Beauchemin, M., & Bertrand, R. (2007) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.2007.b0377 · Cited by 152
Insua‐Rodríguez, J., Pein, M., Hongu, T., Meier, J., Descot, A., Lowy, C. M., De Braekeleer, E., Sinn, H., Spaich, S., Sütterlin, M., et al. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201809003 · Cited by 110
“Intracellular stress can arise from overexpression of oncogenes, poor protein folding, and a high replicative state (Bartkova et al, 2006; Di Micco et al, 2006; Clarke et al, 2014; Minocherhomji et al, 2015).”
BackgroundYin, Y., Xu, L., Chang, Y., Zeng, T., Chen, X., Wang, A., Groth, J., Foo, W., Liang, C. Y., Hu, H., et al. (2019) · Molecular Cancer · doi:10.1186/s12943-019-0941-2 · Cited by 119
Breunig, M., Merkle, J., Wagner, M., Melzer, M. K., Barth, T. F. E., Engleitner, T., Krumm, J., Wiedenmann, S., Cohrs, C. M., Perkhofer, L., et al. (2021) · Cell Stem Cell · doi:10.1016/j.stem.2021.03.005 · Cited by 110
Doksani, Y., Bermejo, R., Fiorani, S., Haber, J. E., & Foiani, M. (2009) · Cell · doi:10.1016/j.cell.2009.02.016 · Cited by 123
Cell Senescence: A Challenge in Cartilage Engineering and Regeneration
Li, J., & Pei, M. (2012) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2011.0583 · Cited by 114
Synthetic Lethal Approaches Exploiting DNA Damage in Aggressive Myeloma
Cottini, F., Hideshima, T., Suzuki, R., Tai, Y.-T., Bianchini, G., Richardson, P. G., Anderson, K. C., & Tonon, G. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0943 · Cited by 115
“Indeed, oncogeneinduced replicative stress is often associated with enhanced expression of components of the replication machinery (7).”
BackgroundMetabolic stress is a barrier to Epstein–Barr virus-mediated B-cell immortalization
McFadden, K., Hafez, A. Y., Kishton, R., Messinger, J. E., Nikitin, P. A., Rathmell, J. C., & Luftig, M. A. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1517141113 · Cited by 118
ATM Couples Replication Stress and Metabolic Reprogramming during Cellular Senescence
Aird, K. M., Worth, A. J., Snyder, N. W., Lee, J. V., Sivanand, S., Liu, Q., Blair, I. A., Wellen, K. E., & Zhang, R. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.04.014 · Cited by 113
“Similar to previous reports (Bartkova et al., 2006; Di Micco et al., 2006), RAS-induced senescence was suppressed by shATM (Figures S1W and S1X).”
Tommiska, J., Bártková, J., Heinonen, M., Hautala, L. C., Kilpivaara, O., Eerola, H., Aittomäki, K., Hofstetter, B., Lukáš, J., von Smitten, K., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210885 · Cited by 129
“…was recapitulated in multiple xenograft and cell culture models of oncogene activation (Bartkova et al., 2005a, 2006; Gorgoulis et al., 2005; Di Micco et al., 2006; Mallette et al., 2007), these studies suggest that the DDR network may function as a biological barrier against cancer…”
Backgroundvan Riggelen, J., Müller, J., Otto, T., Beuger, V., Yetil, A., Choi, P. S., Kosan, C., Möröy, T., Felsher, D. W., & Eilers, M. (2010) · Genes & Development · doi:10.1101/gad.585710 · Cited by 107
Seo, J., Kim, S. C., Lee, H.-S., Kim, J. K., Shon, H. J., Salleh, N. L. M., Desai, K. V., Lee, J. H., Kang, E.-S., Kim, J. S., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks287 · Cited by 130
“Activated oncogenes result in the continuous formation of endogenous DSBs (6) due to increased replication stress (7,8).”
BackgroundViral Oncogene–Induced DNA Damage Response Is Activated in Kaposi Sarcoma Tumorigenesis
Koopal, S., Furuhjelm, J. H., Järviluoma, A., Jäämaa, S., Pyakurel, P., Pussinen, C., Wirzenius, M., Biberfeld, P., Alitalo, K., Laiho, M., et al. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030140 · Cited by 108
“Candidate inducers of the response include oncogenes such as Myc [3,4], Ras [5], Cdc6 [1], Cdc25A, E2F1, or overexpressed cyclin E [6].”
Zhang, X.-B., Beard, B. C., Trobridge, G. D., Wood, B. L., Sale, G. E., Sud, R., Humphries, R. K., & Kiem, H.-P. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34371 · Cited by 108
Autophagy and senescence in cancer therapy
Gewirtz, D. A. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24420 · Cited by 107
Targeting senescence as an anticancer therapy
Bousset, L., & Gil, J. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13312 · Cited by 105
A Proteomic Atlas of Senescence-Associated Secretomes for Aging Biomarker Development
(2019) · doi:10.1101/604306 · Cited by 110
Bacterial intoxication evokes cellular senescence with persistent DNA damage and cytokine signalling
Blazkova, H., Krejcikova, K., Moudry, P., Frisan, T., Hodny, Z., & Bartek, J. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00862.x · Cited by 99
“The biological impact of the activated DDR barrier in human premalignant lesions and cellular models varies according to cell types and specific oncogenic insult, however the predominant cell fates induced by such oncogenic stress are either cell death (often apoptosis) or a long-term cell-cycle arrest state known as…”
BackgroundInfluentialKatlinskaya, Y. V., Katlinski, K. V., Yu, Q., Ortiz, A., Beiting, D. P., Brice, A., Davar, D., Sanders, C., Kirkwood, J. M., Rui, H., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.03.006 · Cited by 108
“Activation of DNA damage responses plays a central role in the development of OIS (Bartkova et al., 2006; Di Micco et al., 2006).”
BackgroundIntegrating the DNA damage and protein stress responses during cancer development and treatment
Gorgoulis, V. G., Pefani, D., Pateras, I. S., & Trougakos, I. P. (2018) · The Journal of Pathology · doi:10.1002/path.5097 · Cited by 108
“Its phosphorylation status determines whether the cell will bypass the “restriction point” of G1 phase committing the cell to progress to S phase without the requirements of extracellular stimulants [112-333].”
BackgroundTo clear, or not to clear (senescent cells)? That is the question
Lujambio, A. (2016) · BioEssays · doi:10.1002/bies.201670910 · Cited by 108
ATM Deficiency Is Associated with Sensitivity to PARP1- and ATR Inhibitors in Lung Adenocarcinoma
Schmitt, A., Knittel, G., Welcker, D., Yang, T.-P., George, J., Nowak, M., Leeser, U., Büttner, R., Perner, S., Peifer, M., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-3398 · Cited by 118
Haffner, M. C., Marzo, A. M. D., Meeker, A. K., Nelson, W. G., & Yegnasubramanian, S. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2044 · Cited by 119
“This transcriptionassociated TIN model would be somewhat distinct and complementary to other forms of genomic instability that are typically thought to be connected to errors in DNA replication (31, 42, 43).”
BackgroundSCFCyclin F-dependent degradation of CDC6 suppresses DNA re-replication
Walter, D., Hoffmann, S., Komseli, E.-S., Rappsilber, J., Gorgoulis, V. G., & Sørensen, C. S. (2016) · Nature Communications · doi:10.1038/ncomms10530 · Cited by 109
Endogenous DNA replication stress results in expansion of dNTP pools and a mutator phenotype
Davidson, M. B., Katou, Y., Keszthelyi, A., Sing, T. L., Xia, T., Ou, J., Vaisica, J. A., Thevakumaran, N., Marjavaara, L., Myers, C. L., et al. (2012) · The EMBO Journal · doi:10.1038/emboj.2011.485 · Cited by 127
“…to note recent observations that pre-cancerous lesions show evidence of DNA damage response activation (Bartkova et al , 2005; Gorgoulis et al , 2005) and that this activation can result from oncogene expression and the resulting replication stress (Bartkova et al , 2006; Di Micco et al , 2006).”
A three-state model of telomere control over human proliferative boundaries
Cesare, A. J., & Karlseder, J. (2012) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2012.08.007 · Cited by 106
Nelson, D. M., Jaber-Hijazi, F., Cole, J. J., Robertson, N. A., Pawlikowski, J. S., Norris, K. T., Criscione, S. W., Pchelintsev, N. A., Piscitello, D., Stong, N., et al. (2016) · Genome Biology · doi:10.1186/s13059-016-1017-x · Cited by 106
Zheng, L., Dai, H., Zhou, M., Li, X., Liu, C., Guo, Z., Wu, X., Wu, J., Wang, C., Zhong, J., et al. (2012) · Nature Communications · doi:10.1038/ncomms1825 · Cited by 99
p53 Maintains Genomic Stability by Preventing Interference between Transcription and Replication
Yeo, C. Q. X., Alexander, I., Lin, Z., Lim, S., Aning, O. A., Kumar, R., Sangthongpitag, K., Pendharkar, V., Ho, V. H. B., & Cheok, C. F. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.03.011 · Cited by 99
“It is thought that oncogenes cause increased origin firing that ultimately results in the overall spatial and temporal deregulation of DNA replication (Bester et al., 2011; Di Micco et al., 2006; Dominguez-Sola et al., 2007).”
BackgroundHypertranscription and replication stress in cancer
Bowry, A., Kelly, R. D., & Petermann, E. (2021) · Trends in cancer · doi:10.1016/j.trecan.2021.04.006 · Cited by 119
Thaler, S., Hähnel, P. S., Schad, A., Dammann, R., & Schüler, M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-1377 · Cited by 113
Weinberger, M., Mesquita, A., Carroll, T., Marks, L., Yang, H., Zhang, Z., Ludovico, P., & Burhans, W. C. (2010) · Aging · doi:10.18632/aging.100215 · Cited by 104
“In mammals, sustained mitogenic signaling by RAS, AKT and other oncogenes increases levels of O2 and other forms of ROS [22] and induces replication stress in cells that growth arrest in S phase instead of G0/G1 during differentiation [23].”
BackgroundPrevention of DNA re-replication in eukaryotic cells
Truong, L. N., & Wu, X. (2011) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjq052 · Cited by 119
“…E, and Cdc25A, induce unscheduled DNA replication or DNA re-replication at pre-cancerous stages of tumorigenesis, generating signals to activate DNA damage checkpoint response, and subsequent loss of checkpoint barriers leads to tumorigenesis (Bartkova et al., 2005, 2006; Di Micco et al., 2006).”
Cellular features of senescence during the evolution of human and murine ductal pancreatic cancer
Caldwell, M. E., DeNicola, G. M., Martins, C. P., Jacobetz, M. A., Maitra, A., Hruban, R. H., & Tuveson, D. A. (2012) · Oncogene · doi:10.1038/onc.2011.350 · Cited by 97
“…of cancer development (Braig et al., 2005; Collado et al., 2005; Michaloglou et al., 2005; Bartkova et al., 2006; Courtois-Cox et al., 2006; Di Micco et al., 2006; Dankort et al., 2007; Sun et al., 2007; Halazonetis et al., 2008; Majumder et al., 2008; Dhomen et al., 2009), following an…”
Venkatachalam, G., Surana, U., & Clément, M.-V. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx684 · Cited by 98
“In addition, evidence from the literature suggest that oncogenic stimuli that do not induce direct DNA damage also mediate senescence via replication stress-induced endogenous DNA damage (56,57).”
BackgroundSOCS1 regulates senescence and ferroptosis by modulating the expression of p53 target genes
Saint-Germain, E., Mignacca, L., Vernier, M., Bobbala, D., Ilangumaran, S., & Ferbeyre, G. (2017) · Aging · doi:10.18632/aging.101306 · Cited by 102
“OIS is triggered by activated oncogenes and involves replication stress, mitochondrial dysfunction, reactive oxygen species and the DNA damage response [30,31,32].”
BackgroundBonagas, N., Gustafsson, N., Henriksson, M., Marttila, P., Gustafsson, R., Wiita, E., Borhade, S. R., Green, A. C., Vallin, K. S. A., Sarno, A., et al. (2022) · Nature Cancer · doi:10.1038/s43018-022-00331-y · Cited by 114
DNA Damage Response Pathways in Tumor Suppression and Cancer Treatment
Liang, Y., Lin, S., Brunicardi, F. C., Goss, J. A., & Li, K. (2008) · World Journal of Surgery · doi:10.1007/s00268-008-9840-1 · Cited by 114
“For example, initiation of human breast, colon, lung, and urinary bladder tumors is characterized by phosphorylation of many proteins in the DDR, including the kinases ATM and ChK2, the histone H2AX, and one of the master regulators of cell cycle, p53 [44, 45 ].”
BackgroundHypoxia and Senescence: The Impact of Oxygenation on Tumor Suppression
Welford, S. M., & Giaccia, A. J. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0065 · Cited by 109
“Oncogene activity can affect both p53 and pRb through several mechanisms, including inducing a DNA damage response due to hyperreplication (3), or by inducing the expression of CDKN2A or CDKN2B (4, 5) that impinges upon pRb activity or p53 stability, respectively.”
BackgroundSigl, R., Wandke, C., Rauch, V., Kirk, J. A., Hunt, T. D., & Geley, S. (2009) · Journal of Cell Science · doi:10.1242/jcs.054197 · Cited by 116
Cellular senescence and tumor promotion: Is aging the key?
Loaiza, N., & Demaria, M. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.01.007 · Cited by 101
Role of Cyclin B1 Levels in DNA Damage and DNA Damage-Induced Senescence
Nakayama, Y., & Yamaguchi, N. (2013) · International review of cytology · doi:10.1016/b978-0-12-407695-2.00007-x · Cited by 112
Nguyen, A. T., Emelyanov, A., Koh, C. H. V., Spitsbergen, J. M., Lam, S. H., Mathavan, S., Parinov, S., & Gong, Z. (2011) · Disease Models & Mechanisms · doi:10.1242/dmm.007831 · Cited by 108
“Excessive activation of Ras signaling can induce DNA damage response (DDR) by DNA replication stress due to aberrant cell proliferation that could prompt the activation of p53-induced senescence as a barrier to tumor progression induced by Ras (DiMicco et al., 2006; Vousden and Prives, 2009).”
Initiation of Genome Instability and Preneoplastic Processes through Loss of Fhit Expression
Saldivar, J. C., Miuma, S., Bene, J., Hosseini, S. A., Shibata, H., Sun, J., Wheeler, L. J., Mathews, C. K., & Huebner, K. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1003077 · Cited by 110
“checkpoints and causes cellular senescence, forming a barrier to cancer progression [7,8].”
BackgroundPIF1 helicase promotes break‐induced replication in mammalian cells
Li, S., Wang, H., Jehi, S. E., Li, J., Liu, S., Wang, Z., Truong, L. N., Chiba, T., Wang, Z., & Wu, X. (2021) · The EMBO Journal · doi:10.15252/embj.2020104509 · Cited by 108
“Oncogene expression often results in replication stress, leading to fork collapse and DSB formation (Bartkova et al , 2006; Di Micco et al , 2006), which is one driving force behind genome instability.”
The stress kinase MKK7 couples oncogenic stress to p53 stability and tumor suppression
Schramek, D., Kotsinas, A., Meixner, A., Wada, T., Elling, U., Pospisilik, J. A., Neely, G. G., Zwick, R. H., Sigl, V., Forni, G., et al. (2011) · Nature Genetics · doi:10.1038/ng.767 · Cited by 113
Polymerase δ replicates both strands after homologous recombination–dependent fork restart
Miyabe, I., Mizuno, K., Keszthelyi, A., Daigaku, Y., Skouteri, M., Mohebi, S., Kunkel, T. A., Murray, J. M., & Carr, A. M. (2015) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3100 · Cited by 110
Replication Stress Shapes a Protective Chromatin Environment across Fragile Genomic Regions
Kim, J., Sturgill, D. M., Sebastian, R., Khurana, S., Tran, A. D., Edwards, G. B., Kruswick, A., Burkett, S. S., Hosogane, E. K., Hannon, W. W., et al. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.11.021 · Cited by 103
“Moreover, RS was found to promote aberrant DDR signaling, which can trigger irreversible cell-cycle arrest in primary cells (Bartkova et al., 2006; Di Micco et al., 2006).”
InfluentialCellular senescence: from growth arrest to immunogenic conversion
Burton, D. G. A., & Faragher, R. (2015) · AGE · doi:10.1007/s11357-015-9764-2 · Cited by 112
Connecting autophagy to senescence in pathophysiology
Young, A. R. J., & Narita, M. (2010) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.12.005 · Cited by 107
Hubáčková, S., Kucerova, A., Michlits, G., Kyjacová, L., Reiniš, M., Korolov, O., Bártek, J., & Hodný, Z. (2015) · Oncogene · doi:10.1038/onc.2015.162 · Cited by 105
The Histone Code of Senescence
Paluvai, H., Di Giorgio, E., & Brancolini, C. (2020) · Cells · doi:10.3390/cells9020466 · Cited by 93
“OIS can occur also in the presence of ectopic TERT expression [6].”
BackgroundInfluentialDNA replication stress: oncogenes in the spotlight
Primo, L. M. F., & Teixeira, L. K. (2020) · Genetics and Molecular Biology · doi:10.1590/1678-4685gmb-2019-0138 · Cited by 102
WRN at telomeres: implications for aging and cancer
Multani, A. S., & Chang, S. (2007) · Journal of Cell Science · doi:10.1242/jcs.03397 · Cited by 95
“…termed cellular senescence, which can be initiated by many stimuli, including dysfunctional telomeres, expression of oncogenes that induce replication-associated stress and oxidative damage (reviewed by Schmitt, 2003; Sharpless and DePinho, 2004; Bartkova et al., 2006; Di Micco et al., 2006).”
BackgroundFunctional heterogeneity in senescence
Kirschner, K., Rattanavirotkul, N., Quince, M. F., & Chandra, T. (2020) · Biochemical Society Transactions · doi:10.1042/bst20190109 · Cited by 89
DNA double-strand break signaling and human disorders
Bohgaki, T., Bohgaki, M., & Hakem, R. (2010) · Genome Integrity · doi:10.1186/2041-9414-1-15 · Cited by 123
DNA damage checkpoint recovery and cancer development
Wang, H., Zhang, X., Teng, L., & Legerski, R. J. (2015) · Experimental Cell Research · doi:10.1016/j.yexcr.2015.03.011 · Cited by 106
Walton, M. I., Eve, P. D., Hayes, A., Valenti, M. R., Brandon, A. K. D. H., Box, G., Hallsworth, A., Smith, E. L., Boxall, K. J., Lainchbury, M. D., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1322 · Cited by 103
The role of senescence in cancer development
Mavrogonatou, E., Pratsinis, H., & Kletsas, D. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.06.018 · Cited by 105
Zampetidis, C. P., Galanos, P., Angelopoulou, A., Zhu, Y., Polyzou, A., Karamitros, T., Kotsinas, A., Lagopati, N., Mourkioti, I., Mirzazadeh, R., et al. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.10.017 · Cited by 87
Inflamm-ageing: How cytokines and nutrition shape the trajectory of ageing
Coperchini, F., Greco, A., Teliti, M., Croce, L., Chytiris, S., Magri, F., Gaetano, C., & Rotondi, M. (2024) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2024.08.004 · Cited by 99
Metadata
- Authors
- Di Micco, R., Fumagalli, M., Cicalese, A., Piccinin, S., Gasparini, P., Luise, C., Schurra, C., Garre’, M., Giovanni Nuciforo, P., Bensimon, A., Maestro, R., Giuseppe Pelicci, P., & d’Adda di Fagagna, F.
- Affiliations
- IFOM (IT)
- European Institute of Oncology (IT)
- Centro di Riferimento Oncologico (IT)
- Institut Pasteur (FR)
- Genomic Vision (France) (FR)
- Venue
- Nature
- Published
- 2006-11
- Volume
- 444
- Issue
- 7119
- Pages
- 638-642
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2121371748
- Cited by
- 1,821
- References
- 30
- Citations by year
- 2026: 50 · 2025: 58 · 2024: 62 · 2023: 76 · 2022: 80 · 2021: 118 · 2020: 84 · 2019: 81 · 2018: 104 · 2017: 84 · 2016: 110 · 2015: 89 · 2014: 118 · 2013: 107 · 2012: 115
- FWCI
- 58.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- oncogene-induced senescence, DNA damage response, H-Ras V12, origin of replication, DNA replication fork progression, cell transformation, carcinogenesis, senescence markers, DNA combing
- MeSH terms
- Animals, Cell Transformation, Neoplastic, Cells, Cultured, DNA Replication, Genetic Markers, Humans, Genes, ras, Cellular Senescence, Cell Proliferation, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.